Fagron NV operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fagron NV with three other pharmaceutical manufacturers in Europe: Amarin Corporation PLC of UNITED KINGDOM (2020 sales of £475.12 million [US$652.63 million] of which 100% was Single segment), Dechra Pharmaceuticals PLC of UNITED KINGDOM (£515.10 million [US$707.56 million] of which 63% was European Pharmaceuticals), and Indivior Plc which is also based in UNITED KINGDOM (£500.60 million [US$687.64 million] of which 78% was Sublingual/Other).

Sales Analysis. During the year ended December of 2020, sales at Fagron NV were 555.97 million Euro (US$660.30 million). This is an increase of 4.0% versus 2019, when the company's sales were 534.70 million Euro. This was the fourth straight year of sales growth at Fagron NV.